Syngen Biotech Co (ROCO:8279) Institutional Ownership: 5.28% (As of Sep. 01, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:8279 Syngen Biotech Co Ltd ROCO:8279
90 GF Score
Price NT$80.00
GF Value NT$133.15
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Syngen Biotech Co Institutional Ownership?

Syngen Biotech Co ROCO:8279 -0.62% 90 Institutional Ownership is 5.28% as of Sep. 01, 2026. GuruFocus rates ROCO:8279 with a GF Score™ of 90/100 and a GF Value™ of NT$133.15 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Syngen Biotech Co's institutional ownership is 5.28%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Syngen Biotech Co's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Syngen Biotech Co's Float Percentage Of Total Shares Outstanding is 0.00%.

Syngen Biotech Co Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Syngen Biotech Co's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Syngen Biotech Co Institutional Ownership Chart

Syngen Biotech Co Historical Data

The historical data trend for Syngen Biotech Co can be seen below:

2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30 2026-07-31
Institutional Ownership 5.36 5.36 5.35 5.35 5.35 5.35 5.35 5.35 5.28 5.28
ROCO:8279
90GF Score
Syngen Biotech Co Ltd ROCO:8279
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Syngen Biotech Co Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 5.28% mean?
Syngen Biotech Co (ROCO:8279) has a Institutional Ownership of 5.28% as of Sep. 01, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Syngen Biotech Co and its competitors.
Is Syngen Biotech Co's Institutional Ownership too high?
Syngen Biotech Co's current Institutional Ownership is 5.28%. Overall, Syngen Biotech Co has a GF Score™ of 90/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Syngen Biotech Co's Institutional Ownership compare to VRTX and REGN?
Syngen Biotech Co's Institutional Ownership of 5.28% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Syngen Biotech Co and its competitors. Syngen Biotech Co's current Institutional Ownership is 5.28%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Syngen Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Syngen Biotech Co (ROCO:8279) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$133.15, compared to a current price of NT$80.00 — trading 39.9% below its estimated fair value. The current Institutional Ownership is 5.28%. Syngen Biotech Co's overall GF Score™ is 90/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Syngen Biotech Co (ROCO:8279), the current Institutional Ownership is 5.28% as of Sep. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Syngen Biotech Co (ROCO:8279) Overvalued in 2026?

Based on GuruFocus' analysis, Syngen Biotech Co stock appears to be undervalued. The current stock price of NT$80.00 is trading 39.9% below its estimated GF Value™ of NT$133.15. GuruFocus considers Syngen Biotech Co to be Significantly Undervalued.

Key valuation signals for ROCO:8279:

  • Institutional Ownership: 5.28%
  • GF Value™: NT$133.15 vs. price of NT$80.00 (39.9% below fair value)
  • GF Score™: 90/100 with 3 warning signs

No single metric tells the full story. See the ROCO:8279 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Syngen Biotech Co Business Description

Address Building A, NO.154, Kai-Yuan Road, Xinying District, Tainan, TWN, 73055
Syngen Biotech Co Ltd is a biotechnology company. It is engaged in the manufacturing, sales, and trading of microbial pharmaceutical raw materials. It also provides the design and development of health food and biochemical nutrition. The company's products include pharmaceutical ingredients, nutritional ingredients, biology fermentation products, biology agriculture and aquaculture products.
90GF Score

Get the complete analysis for ROCO:8279

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$80.00
Price
NT$133.15
GF Value